These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3014268)

  • 21. The optimal technological approach to the development of human hybridomas.
    Dorfman NA
    J Biol Response Mod; 1985 Jun; 4(3):213-39. PubMed ID: 2991473
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion.
    Neil GA; Sammons DW
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):201-5. PubMed ID: 1477301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
    Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies: convergence of technology and application.
    Raff HV
    Prog Clin Biol Res; 1986; 211():247-63. PubMed ID: 3008195
    [No Abstract]   [Full Text] [Related]  

  • 26. [Monoclonal antibodies to RPMI-1788 lymphoblastoid line cells].
    Pinchuk VG; Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN
    Eksp Onkol; 1986; 8(6):41-6. PubMed ID: 3026773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of electric-field-mediated cell fusion to produce hybridomas secreting monoclonal antibodies.
    Zhao X
    Methods Mol Biol; 1995; 45():61-7. PubMed ID: 7550693
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High yields of specific hybridomas obtained by electrofusion of murine lymphocytes immunized in vivo or in vitro.
    van Duijn G; Langedijk JP; de Boer M; Tager JM
    Exp Cell Res; 1989 Aug; 183(2):463-72. PubMed ID: 2767160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient preparation of human monoclonal antibody-secreting heterohybridomas using peripheral B lymphocytes cultured in the CD40 system.
    Darveau A; Chevrier MC; Néron S; Delage R; Lemieux R
    J Immunol Methods; 1993 Feb; 159(1-2):139-43. PubMed ID: 7680365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 32. Why hybridomas?
    Köhler G
    Hybridoma; 1981; 1(1):1-4. PubMed ID: 6985380
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
    Borrebaeck CA
    Scand J Immunol; 1983 Jul; 18(1):9-12. PubMed ID: 6192490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative phenotypic analysis of available human hybridoma fusion partners.
    Kozbor D; Roder JC; Sierzega ME; Cole SP; Croce CM
    Methods Enzymol; 1986; 121():120-40. PubMed ID: 3014264
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
    Seregina TM; Mekshenkov MI
    Tsitologiia; 1986 Sep; 28(9):976-80. PubMed ID: 3798564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-frequency production of cell-surface antigen-specific hybridomas.
    Samoszuk MK; Parker JW
    Hybridoma; 1984; 3(3):293-5. PubMed ID: 6334013
    [No Abstract]   [Full Text] [Related]  

  • 37. [A strategy for the production of human monoclonal antibodies].
    Chiba J
    Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spleen cell analysis and optimal immunization for high-frequency production of specific hybridomas.
    Stähli C; Staehelin T; Miggiano V
    Methods Enzymol; 1983; 92():26-36. PubMed ID: 6304456
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.